Bisphosphonates for Secondary Prevention of Osteoporotic Fractures: A Bayesian Network Meta-Analysis of Randomized Controlled Trials

<div>Evidence network of eligible comparisons for Bayesian network meta-analysis according to (a) new vertebral fractures, (b) new hip fractures, and (c) new nonvertebral nonhip fractures (A, Placebo; B, Alendronate; C, Ibandronate; D, Risedronate; E, Zoledronate; F, Etidronate).</div>

BioMed Research International

fig2

Figure 2

Figure 2: Bisphosphonates for Secondary Prevention of Osteoporotic Fractures: A Bayesian Network Meta-Analysis of Randomized Controlled Trials 